| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2026―Apr―29 |
Clinical course of community-acquired pneumonia of coronavirus etiology in patients with metabolic dysfunction-associated steatotic liver disease |
O. S. Khukhlina, I. V. Rachynska |
| 2 |
[GO] |
2025―Oct―10 |
Impact of prior COVID-19 infection on cardiac surgery outcomes: optimal timing for valvular heart disease surgery |
D. M. Kosovan |
| 3 |
[GO] |
2025―Jul―07 |
A case of progressive acute respiratory distress syndrome in a patient with coronavirus disease (COVID-19) and difficulties in its confirmation by instrumental diagnostic methods |
V. V. Cherkaskyi, K. V. Kalashnyk, O. V. Riabokon |
| 4 |
[GO] |
2025―Feb―20 |
The role of anticoagulants in the treatment of community-acquired pneumonia in patients combined with coronavirus infection |
I. M. Fushtei, V. O. Mochonyi, O. V. Soloviov |
| 5 |
[GO] |
2025―Feb―20 |
Predictive value of the Elixhauser comorbidity index in assessing the risk of coronavirus disease (COVID-19) mortality in patients with pneumonia |
I. O. Kuliesh, O. V. Riabokon, K. V. Kalashnyk |
| 6 |
[GO] |
2025―Feb―20 |
Studying associative relations between left ventricular dysfunction and heart failure development in patients with acute coronary syndrome and clinical manifestation of COVID-19 |
D. V. Bondarets, K. V. Rudenko |
| 7 |
[GO] |
2024―Dec―04 |
The endothelial NO synthase content in the blood serum of patients with coronavirus disease (COVID-19) with pneumonia in association with hemostatic parameters depending on the clinical course and its prognostic significance |
O. V. Riabokon, I. O. Kuliesh, I. F. Bielenichev, Yu. Yu. Riabokon |
| 8 |
[GO] |
2024―Oct―04 |
A modern view on the role of single nucleotide polymorphism of human genes in the formation of unfavorable consequences of the new coronavirus disease (COVID-19) |
Yu. Yu. Riabokon, E. M. Huseynov, K. V. Kalashnyk |
| 9 |
[GO] |
2024―Oct―04 |
Prosthetic valve thrombosis in a patient secondary to COVID-19: a case report |
L. V. Rasputina, D. V. Didenko |
| 10 |
[GO] |
2024―Jul―17 |
Etiological and immunopathogenetic aspects of multiorgan failure development in coronavirus disease (COVID-19) |
T. V. Ashcheulova, N. M. Herasymchuk, O. A. Kochubiei, U. S. Herasymchuk |
| 11 |
[GO] |
2024―Jun―06 |
Long-term sequelae of coronavirus disease: long COVID-19 and cardiovascular outcomes (a literature review) |
A. V. Hovornyan, T. O. Ilashchuk |
| 12 |
[GO] |
2024―Jun―06 |
Diagnostic value of lung ultrasonographic parameters in predicting outcomes of coronavirus disease 2019 (COVID-19) in oxygen-dependent patients requiring intensive care unit treatment |
K. V. Kalashnyk, M. Yu. Kolesnyk, O. V. Riabokon, V. V. Cherkaskiy |
| 13 |
[GO] |
2024―Apr―30 |
Characteristics of neurovegetative disorders in ischemic heart disease patients after coronavirus disease 2019 (COVID-19) |
S. M. Manuilov, N. S. Mikhailovska |
| 14 |
[GO] |
2023―Oct―20 |
A case of severe COVID-19 and influenza co-infection |
O. V. Riabokon, O. O. Furyk, K. V. Kalashnyk |
| 15 |
[GO] |
2023―Oct―20 |
The impact of overall obesity on serotonin level in the acute phase of coronavirus infection and post-coronavirus sequelae: aspects of neuropsychological and cognitive impairments |
O. V. Zinych, N. M. Kushnarova, A. A. Shuprovych, O. M. Trofymenko |
| 16 |
[GO] |
2023―Jul―27 |
Multisystem inflammatory syndrome in a child associated with COVID-19: a clinical case report |
N. S. Kosmynina, M. I. Dats-Opoka |
| 17 |
[GO] |
2023―Jun―09 |
Psychoemotional state and bioelectrical brain activity in patients of different ages with metabolic syndrome after COVID-19 |
V. P. Chyzhova, O. V. Korkushko, V. B. Shatylo, A. V. Pysaruk, V. V. Kuznietsov, O. H. Skrypchenko, et al. (+2) T. I. Kovtonyuk, I. A. Samots |
| 18 |
[GO] |
2023―Mar―29 |
Extrapulmonary manifestations of coronavirus disease (COVID-19): current status (a literature review) |
O. V. Riabokon, K. A. Pak, Yu. Yu. Riabokon, O. O. Furyk, V. V. Cherkaskyi |
| 19 |
[GO] |
2023―Mar―29 |
Hypoglycemia in patients with COVID-19: risk factors and prevention of complications |
O. A. Halushko, O. V. Protsiuk, O. I. Pohorila |
| 20 |
[GO] |
2023―Mar―29 |
Ferritin level predicts in-hospital mortality in hypertensive patients with COVID-19 |
O. Z. Skakun, N. M. Seredyuk |
| 21 |
[GO] |
2022―Sep―09 |
The course of multidrug-resistant pulmonary tuberculosis in HIV-infected people with COVID-19 |
O. M. Raznatovska, Yu. V. Myronchuk, O. S. Shalmin, A. V. Fedorets |
| 22 |
[GO] |
2022―Jul―22 |
Clinical manifestations of cardiovascular disease in children as a sequela of coronavirus disease (COVID-19) (a clinical case) |
Yu. V. Horodkova, M. Yu. Kurochkin, A. H. Davydova, O. I. Podlianova |
| 23 |
[GO] |
2022―Jul―22 |
Gastrointestinal manifestations of COVID-19-associated multisystem inflammatory response syndrome in children |
І. Yu. Avramenko, N. S. Kosmynina, U. Ye. Pidvalna, N. R. Basa |
| 24 |
[GO] |
2022―Mar―18 |
Classification of stressful factors associated with COVID-19 pandemic and quarantine among Ukrainian military personnel |
N. V. Danilevska |
| 25 |
[GO] |
2022―Mar―18 |
Monitoring and assessment of SARS-CoV-2 evolution |
V. V. Miasoiedov, P. V. Nartov, K. V. Yurko, V. M. Lesovoy, V. A. Kapustnyk, A. V. Bondarenko, et al. (+5) M. Ye. Cherniak, V. A. Yakushchenko, V. V. Kucheriavchenko, V. S. Maslova, O. V. Bondarenko |
| 26 |
[GO] |
2022―Jan―10 |
Quercetin effectiveness in patients with COVID-19 associated pneumonia |
I. A. Zupanets, О. А. Holubovska, O. O. Tarasenko, N. P. Bezuhla, M. F. Pasichnyk, S. O. Karabynosh, et al. (+8) V. S. Kopcha, L. V. Moroz, H. V. Maksymchuk, O. Ya. Kobrynska, R. M. Fishchuk, D. I. Schulha, R. S. Morochkovskyj, M. S. Zoshchak |
| 27 |
[GO] |
2022―Jan―10 |
Incidence of cardiac arrhythmias in patients with COVID-19 infection according to 24-hour electrocardiogram monitoring |
V. O. Zbitnieva, O. B. Voloshyna, I. V. Balashova, O. R. Dukova, I. S. Lysyi |
| 28 |
[GO] |
2022―Jan―10 |
Morbidity analysis of pharmacists during the COVID-19 pandemic (a literature review) |
M. V. Bilous, M. M. Bilynska |
| 29 |
[GO] |
2022―Jan―10 |
Use of tocilizumab in the combination treatment of a COVID-19 patient with concomitant rheumatoid arthritis (a case report) |
V. A. Vizir, A. S. Sadomov, O. V. Demidenko |
| 30 |
[GO] |
2022―Jan―10 |
Features of the coronavirus disease course in young children |
N. S. Kosmynina, I. Yu. Avramenko |
| 31 |
[GO] |
2022―Jan―10 |
Ozone therapy as a component of a comprehensive rehabilitation program for patients after polysegmental pneumonia associated with SARS-CoV2 infection |
I. B. Baranova, A. F. Gumeniuk, A. I. Semenenko, I. A. Iliuk, I. P. Osypenko |
| 32 |
[GO] |
2021―Sep―03 |
Inflammatory damage to the myocardium in patients with novel coronavirus disease (COVID-19) |
V. V. Buheruk, O. B. Voloshyna, І. V. Balashova |
| 33 |
[GO] |
2021―Sep―03 |
Features of comorbid pathology spectrum and age structure of oxygen-dependent patients with severe coronavirus disease 2019 (COVID-19) depending on outcomes of the disease |
O. V. Riabokon, V. V. Cherkaskyi, T. Ye. Onishchenkо, Yu. Yu. Riabokon |
| 34 |
[GO] |
2021―Sep―03 |
Pneumonia caused by SARS-COV-2: diagnosis and treatment in outpatient settings |
V. P. Melnyk, O. V. Panasiuk, H. V. Sadomova-Andrianova, I. V. Antoniuk, I. O. Sliusarchuk, H. Ya. Solonynka |
